Decas Earns Cranberry Patent for Controlling Metabolic Syndrome
The company now holds 10 worldwide cranberry ingredient patents.
Decas Botanical Synergies LLC (Carver, MA) has secured a cranberry-based patent, U.S. patent #8,173,178, for controlling metabolic syndrome. The patent is labeled “Compositions and methods for controlled metabolic syndrome using whole fruit-derived cranberry ingredient profile enriched in stress adopted bioactives (SABs).”
“We look forward to partnering with leading nutritional supplement and healthcare providers to penetrate the market for natural cranberry-based solutions for controlling metabolic syndrome,” said Dan Souza, senior director of sales and marketing at Decas Botanical. “This patent, coupled with out published work linking cranberry to prostate health, illustrates DBS’ commitment to expanding the cranberry market beyond prevention of urinary tract infections.”
Decas now holds 10 worldwide patents for cranberry ingredients.
Judge denies CRN’s motion for preliminary injunction but its lawsuit against NY state will proceed
April 23rd 2024The judge in CRN's lawsuit against NY state's law banning the sale of weight management and muscle building supplements to minors has denied its motion for a preliminary injunction, but determined that CRN has standing to sue on behalf of its members.
CRN NY State lawsuit update: Dispatch from SupplySide East 2024
April 18th 2024CRN's Steve Mister updates Nutritional Outlook about its ongoing litigation against NY State. The organization sued the state to prevent the enforcement of law that bans sale of weight management supplements to minors.
Microalgae extract supports metabolic health and bone mass during diet and exercise routine
April 11th 2024The extract from Microphyt, called PhaeOptim, was shown to complement weight management strategies that include diet and exercise by support bone mass, aerobic capacity, resting heart rate, and blood lipid profiles.
